Search research articles
Contact Us
Filters
Showing results (31-40 of 90) with videos related to
Page
of 9
Sort By:
Chemotherapy
|
December 5, 2015
Efficacy and Safety of Carboplatin and Etoposide Combination Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma: A Retrospective Case Series
Hiroo Imai, Hidekazu Shirota, Akira Okita, et al.
Redox Biology
|
August 20, 2025
Cisplatin-induced genetic alterations in KEAP1 promote therapeutic resistance in head and neck squamous cell carcinoma
Yuki Nakayama, Keiko Taguchi, Shun Wakamori, et al.
Cancer Science
|
September 26, 2024
Specific cancer types and prognosis in patients with variations in the KEAP1-NRF2 system: A retrospective cohort study
Tomoyuki Iwasaki, Hidekazu Shirota, Keiju Sasaki, et al.
Translational Oncology
|
April 17, 2025
Dynamic predictive power of TP53 signatures in breast cancer prognosis: Pre- and post-neoadjuvant chemotherapy insights
Keiju Sasaki, Shin Takahashi, Kota Ouchi, et al.
Clinical Colorectal Cancer
|
June 24, 2023
TP53 Gain-of-Function Mutation is a Poor Prognostic Factor in High-Methylated Metastatic Colorectal Cancer
Shonosuke Wakayama, Kota Ouchi, Shin Takahashi, et al.
Annals of Palliative Medicine
|
February 7, 2021
Patients' understanding of communication about palliative care and health condition in Japanese patients with unresectable or recurrent cancer: a cross-sectional survey
Yusuke Hiratsuka, Takayuki Oishi, Mitsunori Miyashita, et al.
Case Reports in Oncology
|
September 26, 2022
BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation
Ken Saijo, Hiroo Imai, Hiromichi Katayama, et al.
Japanese Journal of Clinical Oncology
|
January 26, 2025
A case of Li-Fraumeni syndrome caused by a 3.6 kb deletion in the TP53 gene suggested by additional data from the NCC Oncopanel
Satoshi Souma, Maki Ogawa, Shin Ito, et al.
International Journal of Clinical Oncology
|
December 12, 2019
Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei
Sakura Hiraide, Keigo Komine, Yuko Sato, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 2015
Effect of TLR agonists on the differentiation and function of human monocytic myeloid-derived suppressor cells
Jing Wang, Yuko Shirota, Defne Bayik, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 90) with videos related to
Sort By:
Page
of 9
Chemotherapy
|
December 5, 2015
Efficacy and Safety of Carboplatin and Etoposide Combination Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma: A Retrospective Case Series
Hiroo Imai, Hidekazu Shirota, Akira Okita, et al.
Redox Biology
|
August 20, 2025
Cisplatin-induced genetic alterations in KEAP1 promote therapeutic resistance in head and neck squamous cell carcinoma
Yuki Nakayama, Keiko Taguchi, Shun Wakamori, et al.
Cancer Science
|
September 26, 2024
Specific cancer types and prognosis in patients with variations in the KEAP1-NRF2 system: A retrospective cohort study
Tomoyuki Iwasaki, Hidekazu Shirota, Keiju Sasaki, et al.
Translational Oncology
|
April 17, 2025
Dynamic predictive power of TP53 signatures in breast cancer prognosis: Pre- and post-neoadjuvant chemotherapy insights
Keiju Sasaki, Shin Takahashi, Kota Ouchi, et al.
Clinical Colorectal Cancer
|
June 24, 2023
TP53 Gain-of-Function Mutation is a Poor Prognostic Factor in High-Methylated Metastatic Colorectal Cancer
Shonosuke Wakayama, Kota Ouchi, Shin Takahashi, et al.
Annals of Palliative Medicine
|
February 7, 2021
Patients' understanding of communication about palliative care and health condition in Japanese patients with unresectable or recurrent cancer: a cross-sectional survey
Yusuke Hiratsuka, Takayuki Oishi, Mitsunori Miyashita, et al.
Case Reports in Oncology
|
September 26, 2022
BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation
Ken Saijo, Hiroo Imai, Hiromichi Katayama, et al.
Japanese Journal of Clinical Oncology
|
January 26, 2025
A case of Li-Fraumeni syndrome caused by a 3.6 kb deletion in the TP53 gene suggested by additional data from the NCC Oncopanel
Satoshi Souma, Maki Ogawa, Shin Ito, et al.
International Journal of Clinical Oncology
|
December 12, 2019
Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei
Sakura Hiraide, Keigo Komine, Yuko Sato, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 2015
Effect of TLR agonists on the differentiation and function of human monocytic myeloid-derived suppressor cells
Jing Wang, Yuko Shirota, Defne Bayik, et al.
Page
of 9